BB Biotech AG announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was CHF 1,191.239 million compared to CHF 467,000 a year ago. Net income was CHF 1,179.660 million compared to net loss of CHF 335.805 million a year ago. Basic earnings per share was CHF 21.29 compared to basic loss per share of CHF 6.06 a year ago. For the half year, total revenue was CHF 444.759 million compared to CHF 579.336 million a year ago. Net income was CHF 421.706 million compared to CHF 553.976 million a year ago. Basic earnings per share was CHF 7.61 compared to CHF 10 a year ago.